R&D Systems™ Recombinant Human CD302/CLEC13A Fc Chimera Protein

Catalog No.	Quantity
10-203-CL050	50 μg

Catalog No. 10-203-CL050 Supplier R&D Systems™ Supplier No. 10203CL050

Description

CD302, also known as CLEC13A and DCL1, is a type I transmembrane C-type lectin receptor

• Identified while cloning human DEC-205 and was termed DCL1 (DEC-205-associated C-type lectin-1)
• In humans, the highest expression of CD302 transcripts was observed in the liver, followed by lungs, spleen, and myeloid PBMC populations including monocytes, granulocytes, and dendritic cells

Specifications

• Accession Number: Q8IX05-1
• For Use With (Application): Bioactivity
• Gene ID (Entrez): 9936
• Molecular Weight (g/mol): 43 kDa
• Purification Method: >90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining
• Quantity: 50 μg
• Source:

  Human embryonic kidney cell, HEK293-derived human CD302/CLEC13A protein

  Human CD302/CLEC13A (Asp23-Asn167) Accession # Q8IX05-1IEGRMDHuman IgG1 (Pro100-Lys330)N-terminus C-terminus

• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70°C as supplied. 1 month, 2 to 8°C under sterile conditions after reconstitution. 3 months, -20 to -70°C under sterile conditions after reconstitution.
• Endotoxin Concentration: <0.10 EU per 1 μg of the protein by the LAL method
• Conjugate: Unconjugated
• Reconstitution: Reconstitute at 500 μg/mL in PBS
• Buffer: Lyophilized from a 0.2 μm filtered solution in PBS